Skip to main content
Caplight Logo









Pabel B.V.

Pabel B.V.

Private
AmsterdamHealthcare & Life Scienceshttps://www.pabel.ai/

Last Round

Accelerator

Oct 21, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Pabel B.V. operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was an Accelerator round in October 2025.

Pabel B.V. is a biotechnology and artificial intelligence company that develops an AI-native platform for analyzing and processing neurophysiological data to accelerate CNS drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Foundation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Pabel B.V. Comparables

Compare Pabel B.V. with similar companies based on industry and business-model similarity.

Pabel B.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beacon Biosignals
77%
Cumulus Neuroscience
75%
NeuraLight
66%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Pabel B.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 21, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Pabel B.V. Investors

Notable investors and investment history

Pabel B.V. investors
InvestorRounds
Nvidia InceptionAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 21, 2025

    Received funding from Google for Startups and Nvidia Inception.

Book a demo to see all signals

For institutional investors. Book with your work email.

Pabel B.V. Filings

Explore SEC and related filing metadata, where available.

Pabel B.V. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Pabel B.V.'s valuation, stock price, and market status.

Is Pabel B.V. a public or private company?

Pabel B.V. is a private company.

What is the current stock price of Pabel B.V.?

Pabel B.V. is a private company, so its shares have no public market price. Caplight tracks Pabel B.V.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Pabel B.V. worth (valuation)?

Valuation information for Pabel B.V. is not publicly available.

Can I buy Pabel B.V. stock?

Pabel B.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Pabel B.V.'s last funding round?

Pabel B.V.'s most recent funding round was Accelerator on October 21, 2025.

Who are the main investors in Pabel B.V.?

Key investors in Pabel B.V. include Nvidia Inception.

Will Pabel B.V. IPO soon?

No public IPO plans have been announced for Pabel B.V..

How can I track Pabel B.V. secondary market activity?

Caplight tracks bids, offers, and trades in Pabel B.V.'s shares on secondary markets.

Firmographic Details

HeadquartersAmsterdam
Employee Range2
Year Founded2025
Last FundingOct 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?